Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma. - Kikuchi K; Kobari Y; Nakamura K; Shibusawa K; Ikeda T; Nakayama T; Fukuda H; Yamamoto T; Yoshida K; Iizuka J; Ishida H; Nagashima Y; et al. (In vivo (Athens, Greece), 2026)